ZARS Pharma, Inc.
1142 West 2320 South ,
Salt Lake City ,
UT ,
84119 ,
United States
Phone: +1 801 350 0202
Revenue: $8M
Industry: Wholesale Drugs & Pharmacy Supplies
Employees: 79
SIC: Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
NAICS: Drugs and Druggists' Sundries Merchant Wholesalers (424210)
Description: ZARS Pharma, Inc., a specialty pharmaceutical company, develops and commercializes topically administered drugs primarily in the area of pain management. Its products include Pliaglis, a topical local anesthetic cream that provides local dermal anesthesia on intact skin prior to painful cosmetic procedures, such as dermatologic laser surgery and dermal filler injections; Synera, a topical patch designed to provide local dermal anesthesia for potentially painful superficial procedures, such as venous access procedures involving needles and immunization injections of children; and Flexicaine, which is designed to provide rapid dermal analgesia to affected skin for the treatment of post-herpetic neuralgia. The company's products also comprise Steroid DuraPeel, a phase-changing gel designed to deliver a steroid locally for an extended period of time for the treatment of corticosteroid-responsive dermatoses, including hand dermatitis and psoriasis; Alprazolam Patch, which is used for treating general anxiety and panic disorders; and Risperidone Patch, which delivers risperidone across the skin at a controlled rate for up to three days. The company was formerly known as ZARS, Inc. and changed its name to ZARS Pharma, Inc. in July, 2007. The company was founded in 1996 and is based in Salt Lake City, Utah. As of May 12, 2011, ZARS Pharma, Inc. operates as a subsidiary of Nuvo Research Inc.
2013-05-04 01:12:54
Contacts - VIEW DETAILS
Other
Director(s)
F.
DeBry,
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Steven
Jurvetson,
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Chief Executive Officer
Executive Vice President(s)
Michael
Ashburn,
Co-Founder, Executive Vice President of Clinical & Regulatory Affairs and Medical Director